Evidence map›Paper›PMID 42129085›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Prediction of Protein Antigen Epitopes from Monoclonal Antibodies by In Silico Molecular Docking.

Tânia Maria Manieri, Gabriela Massaro Barreiros

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tânia Maria ManieriLaboratory of Biopharmaceuticals, Butantan Institute, São Paulo, Brazil. tania.manieri@butantan.gov.br.
Gabriela Massaro BarreirosInterunits Graduate Program in Biotechnology, University of São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies are molecules secreted by B lymphocytes, and among the isotypes the most abundant is of the IgG type. Monoclonal antibodies are macromolecules of high affinity and specificity with their receptors, and may have several mechanisms of action and for this reason they are the most studied therapy for the treatment of complex diseases. The characterization of the antigen-antibody interaction is extremely important in understanding the action and efficacy of the antibody. In silico methods are an increasingly growing choice in the evaluation and characterization of these molecules, due to the constant advancement of bioinformatics tools. Through these methods it is possible to predict the paratope of the antibody and the epitope of the antigen and the best interaction between antigen and antibody. The best interaction of the antigen-antibody complex can be performed by docking methods, where from the 3D structure of the antibody and the antigen it is possible to determine the best binding conformation between the molecules.Of the numerous tools currently available, this chapter will focus on free platforms for academic use. It will be described from the obtaining of the 3D structure of the antibody by homology using the ABodyBuilder platform to the docking by the HADDOCK 2.4. Finally, the methodology for identifying binding residues will be described, using the LigPlot+ software.

Indexed as

Antibodies, MonoclonalAntigensEpitopesMolecular Docking SimulationAntigen-Antibody ComplexComputational BiologyHumansImmunoinformaticsProtein BindingProtein ConformationSoftwareAntibodies, MonoclonalAntigen-Antibody ComplexAntigensEpitopesAntigenDockingEpitopesHaddockIn silicoMonoclonal antibodiesPrediction

Identifiers

PMID42129085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.